Geron reported $44.1M in Trade Debtors for its fiscal quarter ending in March of 2026.





Trade Debtors Change Date
Amgen USD 10.23B 1.09B Jun/2026
Bio Techne USD 214.56M 29.95M Mar/2026
Cassava Sciences USD 117K 3K Mar/2026
Cytokinetics USD 6.83M 10.94M Mar/2026
Exelixis USD 322.21M 6.73M Jun/2026
Genmab DKK 1.22B 192M Jun/2026
Geron USD 44.1M 4.87M Mar/2026
Gilead Sciences USD 5.06B 314M Jun/2026
Incyte USD 1.13B 73.7M Jun/2026
MacroGenics USD 10.42M 2.95M Mar/2026
Novartis USD 9.85B 252M Jun/2026
Novavax USD 106.45M 72.27M Dec/2025